Lantus and Pyoderma - a phase IV clinical study of FDA data

Summary:

Pyoderma is reported as a side effect among people who take Lantus (insulin glargine recombinant), especially for people who are female, 50-59 old, also take Novorapid, and have Dyslipidaemia.

The phase IV clinical study analyzes which people have Pyoderma when taking Lantus. It is created by eHealthMe based on reports of 190,478 people who have side effects when taking Lantus from the FDA, and is updated regularly.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,781 Lantus users. Check the latest studies of Lantus.

What is Pyoderma?

Pyoderma (any skin disease that is pyogenic) is found to be associated with 74 drugs and 168 conditions by eHealthMe. Check the latest studies of Pyoderma.

On May, 02, 2026

190,478 people reported to have side effects when taking Lantus.
Among them, 10 people (0.01%) have Pyoderma.

Among these 10 people:

What is the gender of people who have Pyoderma when taking Lantus? *

female: 60 %
male: 40 %

What is the age of people who have Pyoderma when taking Lantus? *

What are other drugs people take besides Lantus? *

What are other side effects people have besides Pyoderma? *

Glycosylated Haemoglobin Increased: 4 people, 40.00%
Actinomycosis (infection that causes sores, or abscesses): 4 people, 40.00%
Skin Ulcer: 3 people, 30.00%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 3 people, 30.00%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 30.00%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 3 people, 30.00%
Wound Dehiscence (a surgical incision reopens either internally or externally): 1 person, 10.00%
Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 1 person, 10.00%

What are the existing conditions these people have? *

Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 3 people, 30.00%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 30.00%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 3 people, 30.00%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 30.00%
Dyslipidaemia (abnormal amount of lipids): 3 people, 30.00%
Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 1 person, 10.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus and have Pyoderma?

- Check whether Pyoderma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lantus:

Lantus (191,781 reports)

Pyoderma treatments and more:

Pyoderma (816 reports)

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pyoderma:

Pyoderma (74 drugs)

Browse all the conditions that are associated with Pyoderma:

Pyoderma (168 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine recombinant (the active ingredients of Lantus) and Lantus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.